76 related articles for article (PubMed ID: 11789026)
1. Augmentation of antiproliferative and antitumor effect on human cancer cells in combined use of electroporation with a plant toxin, saporin.
Mashiba H; Ozaki Y; Ikuno S; Matsunaga K
Cancer Biother Radiopharm; 2001 Dec; 16(6):495-9. PubMed ID: 11789026
[TBL] [Abstract][Full Text] [Related]
2. Augmented inhibition of tumor cell proliferation in combined use of electroporation with a plant toxin, saporin.
Mashiba H; Ozaki Y; Matsunaga K
Ann N Y Acad Sci; 1999; 886():233-5. PubMed ID: 10667227
[No Abstract] [Full Text] [Related]
3. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
[TBL] [Abstract][Full Text] [Related]
4. Bispecific F(ab' gamma)2 antibody for the delivery of saporin in the treatment of lymphoma.
Glennie MJ; Brennand DM; Bryden F; McBride HM; Stirpe F; Worth AT; Stevenson GT
J Immunol; 1988 Nov; 141(10):3662-70. PubMed ID: 3141503
[TBL] [Abstract][Full Text] [Related]
5. Shock wave permeabilization with ribosome inactivating proteins: a new approach to tumor therapy.
Delius M; Adams G
Cancer Res; 1999 Oct; 59(20):5227-32. PubMed ID: 10537301
[TBL] [Abstract][Full Text] [Related]
6. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU
Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056
[TBL] [Abstract][Full Text] [Related]
7. Cooperative mixtures of bispecific F(ab')2 antibodies for delivering saporin to lymphoma in vitro and in vivo.
French RR; Courtenay AE; Ingamells S; Stevenson GT; Glennie MJ
Cancer Res; 1991 May; 51(9):2353-61. PubMed ID: 2015599
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of growth of breast cancer cells in vitro by the ribosome-inactivating protein saporin 6.
Gasperi-Campani A; Zoli W; Volpi A; Roncuzzi L; Amadori D
Anticancer Res; 1991; 11(2):1007-11. PubMed ID: 2064307
[TBL] [Abstract][Full Text] [Related]
9. Initial experience in treating human lymphoma with a combination of bispecific antibody and saporin.
Bonardi MA; Bell A; French RR; Gromo G; Hamblin T; Modena D; Tutt AL; Glennie MJ
Int J Cancer Suppl; 1992; 7():73-7. PubMed ID: 1428411
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic effects of FGF2-saporin on bovine epithelial lens cells in vitro.
Behar-Cohen FF; David T; Buechler Y; Nova MP; Houston LL; Pouliquen YM; Courtois Y
Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2425-33. PubMed ID: 7591632
[TBL] [Abstract][Full Text] [Related]
11. Saporin toxins directed to basic fibroblast growth factor receptors effectively target human ovarian teratocarcinoma in an animal model.
Davol P; Beitz JG; Mohler M; Ying W; Cook J; Lappi DA; Frackelton AR
Cancer; 1995 Jul; 76(1):79-85. PubMed ID: 8630880
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the performance of anti-CD7 and anti-CD38 bispecific antibodies and immunotoxins for the delivery of saporin to a human T-cell acute lymphoblastic leukemia cell line.
Flavell DJ; Cooper S; Okayama K; Emery L; Flavell SU
Hematol Oncol; 1995; 13(4):185-200. PubMed ID: 7557895
[TBL] [Abstract][Full Text] [Related]
13. Saporin immunotoxins.
Flavell DJ
Curr Top Microbiol Immunol; 1998; 234():57-61. PubMed ID: 9670612
[No Abstract] [Full Text] [Related]
14. In vitro and in vivo efficacy of heat shock protein specific immunotoxins on human tumor cells.
Piselli P; Vendetti S; Poccia F; Cicconi R; Mattei M; Bolognesi A; Stirpe F; Colizzi V
J Biol Regul Homeost Agents; 1995; 9(2):55-62. PubMed ID: 9127634
[TBL] [Abstract][Full Text] [Related]
15. The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma.
Flavell DJ; Warnes SL; Bryson CJ; Field SA; Noss AL; Packham G; Flavell SU
Br J Haematol; 2006 Jul; 134(2):157-70. PubMed ID: 16771848
[TBL] [Abstract][Full Text] [Related]
16. Proliferation inhibition of human cancer cells in combined use of electroporation with attenuated diphtheria toxin.
Mashiba H; Matsunaga K
Cancer Biother Radiopharm; 2003 Oct; 18(5):803-10. PubMed ID: 14629828
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo.
Beitz JG; Davol P; Clark JW; Kato J; Medina M; Frackelton AR; Lappi DA; Baird A; Calabresi P
Cancer Res; 1992 Jan; 52(1):227-30. PubMed ID: 1309225
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effect of basic fibroblast growth factor-saporin mitotoxin on keratocytes in culture.
Wee WR; Parandoosh Z; Sakamoto T; Caton M; Nova M; McDonnell PJ
Korean J Ophthalmol; 1996 Jun; 10(1):1-7. PubMed ID: 8755195
[TBL] [Abstract][Full Text] [Related]
19. Systemic therapy with 3BIT, a triple combination cocktail of anti-CD19, -CD22, and -CD38-saporin immunotoxins, is curative of human B-cell lymphoma in severe combined immunodeficient mice.
Flavell DJ; Noss A; Pulford KA; Ling N; Flavell SU
Cancer Res; 1997 Nov; 57(21):4824-9. PubMed ID: 9354445
[TBL] [Abstract][Full Text] [Related]
20. Host-mediated antibody-dependent cellular cytotoxicity contributes to the in vivo therapeutic efficacy of an anti-CD7-saporin immunotoxin in a severe combined immunodeficient mouse model of human T-cell acute lymphoblastic leukemia.
Flavell DJ; Warnes S; Noss A; Flavell SU
Cancer Res; 1998 Dec; 58(24):5787-94. PubMed ID: 9865737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
